Journey Medical Corporation
DERM | NASDAQ
$7.25
+$0.26 (+3.72%)
At close: Sep 22, 2026, 4:00 PM ET
$7.25
$0 (0.00%)
After-hours:
Sep 22, 2026, 7:30 PM ET
Market Data
Market Cap $192.38M
Enterprise Value $192.27M
Beta 1.10
Average Volume 244.37K
Shares Outstanding (Diluted) 27.49M
Shares Change YoY 18.05%
Institutional Ownership 43.46%
Exchange NASDAQ
ISIN US48115J1097
Price Performance
Price Change 1M -10.4%
Price Change 3M 4.3%
Price Change 6M 2.3%
Price Change YTD -6.2%
Price Change 1Y -4.3%
Price Change 3Y 136.9%
Price Change 5Y -26.4%
1M CAGR (ann.) 8.7%
1Y CAGR (ann.) -3.9%
5Y CAGR (ann.) N/A
All-Time CAGR -6.9%
Valuation
PE Ratio -30.39
Forward PE 11.66
PEG Ratio -1.47
Forward PEG 0.02
PS Ratio 2.82
Forward PS 1.50
PB Ratio 5.99
P/FCF Ratio -25.68
P/Adj. FCF Ratio -14.20
P/OCF Ratio -25.89
EV/Sales 2.82
EV/EBIT -79.42
EV/EBITDA 103.99
EV/FCF -25.66
Earnings Yield -3.3%
FCF Yield -3.9%
Adj. FCF Yield -7.0%
Financial Health
Net Cash $102K
Total Debt $25.54M
Cash & Short-Term Investments $25.64M
Total Assets $98.36M
Current Ratio 1.59
Quick Ratio 1.41
Debt / Equity Ratio 0.80
Debt / EBITDA 13.81
Debt / FCF -3.41
OCF / Debt -0.29
Interest Coverage -0.82
Altman Z-Score 1.25
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 62.2%
Operating Profit Margin -4.4%
EBITDA Margin 2.7%
Net Profit Margin -8.9%
FCF Margin -11.0%
Adj. FCF Margin -19.9%
SBC / Revenue 8.9%
SBC Impact (per share) -80.8%
Returns
Return on Assets -6.2%
Return on Equity -20.2%
Return on Invested Capital -5.2%
Return on Capital Employed -5.7%
Return on Tangible Assets -8.4%
Historical Growth (CAGR)
Revenue CAGR 3Y 3.5%
Revenue CAGR 5Y 6.8%
Revenue CAGR 10Y 16.7%
EPS CAGR 3Y -52.4%
EPS CAGR 5Y 64.9%
EPS CAGR 10Y 24.1%
FCF CAGR 3Y 3.9%
FCF CAGR 5Y 34.2%
FCF CAGR 10Y 31.4%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 3
EPS Growth Next 3Y 323.2%
Revenue Growth Next 3Y 48.4%
Earnings Date Nov 10, 2026
EPS Estimate (next Q) $0.02
EPS Growth Est (next Q) -122.2%
Revenue Est (next Q) $21.89M
Revenue Growth Est (next Q) 24.2%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $11.75
Price Target Upside 68.1%
Cash Flow
Operating Cash Flow $-7.49M
Free Cash Flow $-7.49M
Adj. Free Cash Flow $-13.55M
FCF Per Share -$0.27
OCF Per Share -$0.27
OCF/S Ratio -11.0%
Income Statement
Revenue $68.18M
Gross Profit $42.43M
Operating Income $-3.01M
EBITDA $1.85M
Net Income $-6.1M
EPS (Diluted) -$0.23
Revenue / Employee $1.18M
Profit / Employee $-105.24K
Employees 58
Add to Watchlist
Select watchlists to add or remove DERM